tobramycin therapi pulmonari infect patient cystic fibrosi six patient exacerb chronic pulmonari infect associ cystic fibrosi treat intramuscular tobramycin 5 mgkgday 3 divid dose eight treatment cours last 9 30 day mean serum level 25 microgml 1 3 hour 02 microgml 7 12 8 hour dose tobramycin mean tobramycin concentr sputum 03 microgml eightytwo percent 66 pathogen bacteri isol sputum either pseudomona sp 64 staphylococcu aureu 18 ninetyseven percent pseudomona sp 83 percent staphylococcu aureu inhibit 31 microg tobramycin per ml organ isol therapi observ becom resist tobramycin although 3 occas colon new resist gramneg bacilli occur 6 8 cours therapi patient show clinic improv elimin bacteri pathogen sputum rare achiev necessari produc clinic improv colon resist flora uncommon find tobramycin side effect limit local discomfort inject site nausea vomit